H. C. Thomas

3.3k total citations
47 papers, 1.6k citations indexed

About

H. C. Thomas is a scholar working on Epidemiology, Hepatology and Immunology. According to data from OpenAlex, H. C. Thomas has authored 47 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Epidemiology, 36 papers in Hepatology and 6 papers in Immunology. Recurrent topics in H. C. Thomas's work include Hepatitis C virus research (33 papers), Hepatitis B Virus Studies (31 papers) and Liver Disease Diagnosis and Treatment (18 papers). H. C. Thomas is often cited by papers focused on Hepatitis C virus research (33 papers), Hepatitis B Virus Studies (31 papers) and Liver Disease Diagnosis and Treatment (18 papers). H. C. Thomas collaborates with scholars based in United Kingdom, Italy and Netherlands. H. C. Thomas's co-authors include Peter Karayiannis, Janice Main, M G Brook, Mark Thursz, Andrew Lever, Mark Wright, Branwen J. Hennig, Luyin Zhang, Sylvia Knapp and Simon Hellier and has published in prestigious journals such as Gut, Journal of Hepatology and British Journal of Haematology.

In The Last Decade

H. C. Thomas

46 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H. C. Thomas United Kingdom	20	1.1k	1.1k	226	176	161	47	1.6k
Shogo Ohkoshi Japan	15	1.7k 1.5×	1.4k 1.2×	209 0.9×	154 0.9×	376 2.3×	45	2.2k
Heung‐Bum Oh South Korea	19	237 0.2×	312 0.3×	331 1.5×	83 0.5×	267 1.7×	161	1.3k
Stewart Cooper United States	19	1.4k 1.2×	1.3k 1.2×	747 3.3×	144 0.8×	182 1.1×	34	2.2k
Mani Subramanian United States	17	756 0.7×	780 0.7×	78 0.3×	206 1.2×	210 1.3×	62	1.1k
Tilman Gerlach Germany	19	1.9k 1.6×	1.6k 1.4×	689 3.0×	185 1.1×	138 0.9×	25	2.4k
Masahiro Takayanagi Japan	15	1.3k 1.1×	1.1k 1.0×	110 0.5×	129 0.7×	96 0.6×	31	1.5k
Aline Rinfret Canada	11	542 0.5×	512 0.5×	151 0.7×	96 0.5×	240 1.5×	14	949
Wulf O. Böcher Germany	19	918 0.8×	959 0.9×	333 1.5×	245 1.4×	104 0.6×	31	1.3k
C. Bréchot France	15	861 0.8×	919 0.8×	68 0.3×	96 0.5×	220 1.4×	55	1.2k
Christian Bréchot France	15	778 0.7×	785 0.7×	51 0.2×	102 0.6×	213 1.3×	18	1.1k

Countries citing papers authored by H. C. Thomas

Since Specialization

Citations

This map shows the geographic impact of H. C. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. C. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. C. Thomas more than expected).

Fields of papers citing papers by H. C. Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. C. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. C. Thomas. The network helps show where H. C. Thomas may publish in the future.

Co-authorship network of co-authors of H. C. Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of H. C. Thomas. A scholar is included among the top collaborators of H. C. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. C. Thomas. H. C. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sheridan, David, Simon H. Bridge, Mary M.E. Crossey, et al.. (2014). Depressive symptoms in chronic hepatitis C are associated with plasma apolipoprotein E deficiency. Metabolic Brain Disease. 29(3). 625–634. 9 indexed citations

Knapp, Sylvia, Leland J. Yee, A J Frodsham, et al.. (2003). Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR. Genes and Immunity. 4(6). 411–419. 187 indexed citations

Hennig, Branwen J., Simon Hellier, A J Frodsham, et al.. (2002). Association of low-density lipoprotein receptor polymorphisms and outcome of hepatitis C infection. Genes and Immunity. 3(6). 359–367. 52 indexed citations

Thomas, H. C., M. Estée Török, Daniel Forton, & Simon D. Taylor‐Robinson. (1999). Possible mechanisms of action and reasons for failure of antiviral therapy in chronic hepatitis C. Journal of Hepatology. 31. 152–159. 52 indexed citations

Thomas, H. C.. (1998). Mechanism of emergence of hepatitis B virus escape variants: approaches to prevention. Journal of Viral Hepatitis. 5(s2). 31–36. 3 indexed citations

Thomas, H. C. & Mark Thursz. (1997). Immunogenetics of hepatitis B virus infection. Journal of Viral Hepatitis. 4(s2). 98–100. 3 indexed citations

Fattovich, Giovanna, G. Giustina, Françoise Degos, et al.. (1997). Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C. Journal of Hepatology. 27(1). 201–205. 161 indexed citations

Thomas, H. C., et al.. (1997). Predicted secondary structure of the hepatitis G virus and GB virus‐A 5‘ untranslated regions consistent with an internal ribosome entry site. Journal of Viral Hepatitis. 4(3). 175–184. 13 indexed citations

Foster, Graham R., Osiyallê Akanni Silva Rodrigues, Ewert Schulte‐Frohlinde, et al.. (1996). Different Relative Activities of Human Cell-Derived Interferon-α Subtypes: IFN-α8 Has Very High Antiviral Potency. Journal of Interferon & Cytokine Research. 16(12). 1027–1033. 106 indexed citations

10.

Booth, Jonathan, Jonathan Brown, & H. C. Thomas. (1995). The management of chronic hepatitis C virus infection.. Gut. 37(4). 449–454. 30 indexed citations

11.

Carman, William F. & H. C. Thomas. (1993). Implications of genetic variation on the pathogenesis of hepatitis B virus infection. PubMed. 8. 143–154. 2 indexed citations

12.

Karayiannis, Peter, et al.. (1990). Anti-HBs response in seroconverting chronic HBV carriers following alpha-interferon treatment. Journal of Hepatology. 10(3). 350–352. 9 indexed citations

13.

Thomas, H. C.. (1990). The hepatitis B virus and the host response. Journal of Hepatology. 11. S83–S89. 30 indexed citations

14.

Brook, M G, I. Yap, Peter Karayiannis, et al.. (1989). Randomised controlled trial of lymphoblastoid interferon alfa in Europid men with chronic hepatitis B virus infection.. BMJ. 299(6700). 652–656. 68 indexed citations

15.

Brook, M G, J.A. McDonald, Peter Karayiannis, et al.. (1989). Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response.. Gut. 30(8). 1116–1122. 80 indexed citations

16.

Lever, Andrew, M G Brook, I. Yap, & H. C. Thomas. (1987). Treatment of thrombocytopenia with alfa interferon.. BMJ. 295(6612). 1519–1520. 27 indexed citations

17.

Ikeda, Tadashi, Massimo Pignatelli, Andrew Lever, & H. C. Thomas. (1986). Relationship of HLA protein display to activation of 2-5A synthetase in HBe antigen or anti-HBe positive chronic HBV infection.. Gut. 27(12). 1498–1501. 22 indexed citations

18.

Karayiannis, Peter, et al.. (1985). Hepatitis B virus DNA in saliva, urine, and seminal fluid of carriers of hepatitis B e antigen. BMJ. 291(6493). 482.2–482. 3 indexed citations

19.

Jain, S, H. C. Thomas, & S. Sherlock. (1977). Transfer factor in the attempted treatment of patients with HBsAg-positive chronic liver disease.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 30(1). 10–5. 18 indexed citations

20.

Thomas, H. C.. (1977). [Treatment of fever and influenza infections using Chinavit].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 53(9). 508–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact